Axel Lechner
Overview
Explore the profile of Axel Lechner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
453
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lechner A, Haider S, Branz P, Paul B, Kashani F, Canis M, et al.
Heliyon
. 2024 Oct;
10(19):e38044.
PMID: 39416848
Background/objectives: New teaching methods are warranted to meet the demand for increased flexibility in medical education while making optimal use of the limited resources of educators. The COVID-19 pandemic forced...
2.
Mayer M, Esser J, Walker S, Shabli S, Lechner A, Canis M, et al.
Head Face Med
. 2024 Jul;
20(1):38.
PMID: 38997761
Background: A parotid abscess (PA) is a complication of an acute bacterial parotitis with a potentially life-threatening course. To date, data on the diagnosis and therapy of PA is sparse...
3.
Molecular characterization of the evolution of premalignant lesions in the upper aerodigestive tract
Lechner A, Kumbrink J, Walz C, Jung A, Baumeister P, Flach S
Front Oncol
. 2024 May;
14:1364958.
PMID: 38706595
Introduction: Early relapse and development of metastatic disease are some of the primary reasons for the poor prognosis of patients with head and neck squamous cell carcinoma (HNSCC). HNSCC is...
4.
Stachelscheid J, Jiang Q, Aszyk C, Warner K, Bley N, Muller T, et al.
Blood
. 2022 Sep;
141(12):1425-1441.
PMID: 36179280
Upregulation of the proto-oncogene T-cell leukemia/lymphoma 1A (TCL1A) is causally implicated in various B-cell and T-cell malignancies. High-level TCL1A correlates with aggressive disease features and inferior clinical outcomes. However, the...
5.
Mentz M, Keay W, Strobl C, Antoniolli M, Adolph L, Heide M, et al.
Leukemia
. 2022 Jul;
36(9):2281-2292.
PMID: 35851155
The variable clinical course of follicular lymphoma (FL) is determined by the molecular heterogeneity of tumor cells and complex interactions within the tumor microenvironment (TME). IL-4 producing follicular helper T...
6.
Lechner A, Haider S, Paul B, Escrihuela Branz P, Felicio-Briegel A, Widmann M, et al.
J Pers Med
. 2022 May;
12(5).
PMID: 35629203
In medical school, practical capacity building is a central goal. During the COVID-19 pandemic, a shift to online teaching methods in university was mandated in many countries to reduce risk...
7.
Sharaf K, Felicio-Briegel A, Widmann M, Huber J, Eggersmann T, Stadlberger U, et al.
HNO
. 2021 Oct;
70(4):295-303.
PMID: 34622305
Background: A central goal of medical school is acquisition of theoretical and practical competences. However, evidence on how capacity acquisition can be measured for special examination techniques is scarce. ToSkORL...
8.
Sharaf K, Lechner A, Haider S, Wiebringhaus R, Walz C, Kranz G, et al.
Curr Oncol
. 2021 Jul;
28(4):2763-2774.
PMID: 34287293
Cancer stem cells (CSCs) are accountable for the progress of head and neck squamous cell carcinoma (HNSCC). This exploratory study evaluated the expression of molecular CSC markers in different tissues...
9.
Sharaf K, Eggersmann T, Haider S, Schwenk-Zieger S, Zhou J, Gires O, et al.
Cancers (Basel)
. 2021 Jul;
13(11).
PMID: 34206064
Human adipose-derived stem/stromal cells (ASCs) are increasingly used as auto-transplants in regenerative medicine to restore tissue defects or induce wound healing, especially in cancer patients. The impact of ASCs on...
10.
Wennhold K, Thelen M, Lehmann J, Schran S, Preugszat E, Garcia-Marquez M, et al.
Cancer Immunol Res
. 2021 Jun;
9(9):1098-1108.
PMID: 34155067
The role of B cells in antitumor immunity and their impact on emerging immunotherapies is increasingly gaining attention. B-cell effector functions include not only secretion of antibodies, but also presentation...